We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRHC:NASDAQFreedom Holding Corp. Analysis

Data as of 2026-04-04 - not real-time

$151.64

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Freedom Holding Corp. (FRHC) is trading at $151.64, well below its DCF‑derived fair value of $488, suggesting a sizable upside potential. The stock sits just beneath the 20‑day SMA ($139.34) and above the 50‑day SMA ($128.75), while the 200‑day SMA ($147.42) is also supportive, indicating a neutral‑to‑bullish bias. However, the RSI is extremely high at 74.7, flagging an overbought condition, and the MACD histogram remains modest (+0.71) despite a bullish signal, hinting at limited short‑term momentum.
Fundamentally, FRHC reports a meager profit margin of 0.18% and a trailing P/E of 7,582, reflecting near‑zero earnings, yet forward earnings of $4.50 imply a more reasonable forward P/E of ~34. The company holds abundant cash ($3.05 B) but also carries substantial debt ($2.17 B) leading to a high debt‑to‑equity ratio. Recent news highlights rapid fintech expansion, $1.69 B revenue and $144.5 M net income in the first nine months of FY2026, and confirmation of stable credit ratings by S&P, underscoring improving profitability and credit quality. These mixed signals point to a stock that is technically overbought but fundamentally undervalued relative to its intrinsic estimate, with medium‑to‑high risk stemming from volatility (31% 30‑day) and sector‑specific regulatory exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating overbought conditions
  • Price approaching resistance near $152
  • Neutral trend direction with modest MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far above current price
  • Forward earnings growth and improved profitability
  • Increasing trading volume supporting liquidity

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic fintech expansion and diversified revenue streams
  • Stable credit rating and strong cash position
  • Potential for sustained earnings growth despite current low margins

Key Metrics & Analysis

Financial Health

Revenue Growth-14.10%
Profit Margin0.18%
P/E Ratio7582.0
ROE0.22%
ROA0.03%
Debt/Equity155.89
P/B Ratio6.7
Op. Cash Flow$3.1B
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI74.7
Support$127.30
Resistance$152.51
MA 20$139.34
MA 50$128.75
MA 200$147.42
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Fair Value$488.83
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.16
Volatility31.03%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.